Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smart Holograms was a biotechnology company spun out from the University of Cambridge that specialized in the development of holographic sensors. The company's core technology involved the use of smart polymers that change volume in response to specific chemical or biological stimuli, altering the reflected light of a hologram to provide a visible or measurable signal. These sensors were designed for a wide range of applications, including point-of-care glucose monitoring for diabetes, detection of pathogens like anthrax, and monitoring of water quality. The technology aimed to provide a simple, color-changing visual readout that did not require complex electronic readers. Despite significant early investment and several high-profile partnerships, the company eventually ceased operations and was dissolved in 2012.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smart Holograms.